BioForward 2020

8:30

Mezzanine

My Schedule

Conference & Exhibition Open

Monday, 05 Oct 2020

8:30 - 18:00

Exhibition

English

Conference & Exhibition Open

My Schedule

Delegate Registration 8:30-9:30

9:30

L2

My Schedule

Welcome to BioForward 2020

Monday, 05 Oct 2020

9:30 - 9:35

Keynote

English

Welcome to BioForward 2020

My Schedule

Speakers

John Harris

CEO

OBN (UK) Ltd

C2

My Schedule

HR Drop In Clinic

Monday, 05 Oct 2020

9:35 - 11:00

Drop In Session

English

HR Drop In Clinic

My Schedule

L2

My Schedule

Panel: Selecting the Right Board for your Business

Monday, 05 Oct 2020

9:35 - 10:20

Panel Discussion

English

Information Panel

Panel: Selecting the Right Board for your Business

My Schedule

One of the biggest challenges for any company CEO is ensuring they appoint the right individuals to their Board, to achieve the best mix of requisite skills, experience and competencies that can guide and support the long-term success of the organisation.

The board will be responsible for many key decisions within the organisation including its control and accountability systems, final approval of the corporate strategy, risk management and legal compliance, approving and monitoring the progress of major capital expenditure, capital management, and acquisitions and divestitures.

It is important that a potential Board member properly evaluates the organisation before committing, ensuring that their skills and experience fill a gap and compliment the other Board members.

This panel will share information that will guide you on the key areas to consider when forming your board, and potential pitfalls to be aware of, including:

The importance of considering the composition of a board and the dynamics of its personalities; does the team have the patience and fortitude to work through pre-revenue phases?
Ensure you achieve a a good balance of values between scientific research and the commercial and financial skills and experience required to nurture the growth of a pre-revenue business
How will the Board be remunerated/rewarded for the considerable time they will devote to your organisation – what can be offered to board members instead of cash?
Are your Board members truly passionate about the science that is driving the company?
What is their attitude to risk? A considered appetite for risk and an understanding of the commercialisation process, marketing, and business can be a great attribute.
How to deal with a conflict of interest - at board level in the life sciences industry there is generally a smaller pool of appropriate board candidates to choose from, so it is important to ensure all conflicts are declared and dealt with appropriately
Choose your Chair with care – it is important that they are highly experienced in the area you are specialising in, hold considerable gravitas in the industry and act as a respected figurehead for the business

10:20

L2

My Schedule

Panel: What's New in the Regulatory Landscape?

Monday, 05 Oct 2020

10:20 - 11:10

Panel Discussion

English

Information Panel

Panel: What's New in the Regulatory Landscape?

My Schedule

All company owners in the life sciences must maintain a comprehensive, real-time view of the regulations that exist in their industry and ensure that their compliance programs are full integrated into their evolving business strategies.

Regulatory matters must have a front and centre focus throughout the R&D process as well as when new business relationships are explored. By ensuring you are fully compliant you are better supporting your teams and the ongoing work of your organisation.

This panel has been designed to review all that is new in the regulatory landscape of the life sciences industry; and as the UK looks forward to its future outside the EU, we will also address the key areas set to change or be impacted post the transition on 31^st December 2020.

Key topics will include:

An insight into the updates in the published Medicines and Medical Devices Bill – what does this mean for UK life sciences companies after we transition out of the EU, particularly regarding human medicines regulation, clinical trials, and medical devices
What are the the regulatory updates in areas such as using artificial intelligence in treatments?
How can the UK break new ground in complex clinical trials – will the implementation of new regulations make us a more attraction location for external companies?
What aspects of current bureaucratic processes can and should be modified, reduced or eliminated to make the UK system a faster, cheaper and more streamlined market?

11:10

Mezzanine

My Schedule

Networking Break and Partnering Meetings

Monday, 05 Oct 2020

11:10 - 11:30

Social

English

Networking Break and Partnering Meetings

My Schedule

L4

My Schedule

BioLearn Masterclass: How the Drug Discovery Industry Works

Monday, 05 Oct 2020

11:30 - 12:15

BioLearn Masterclass

English

BioLearn Masterclass: How the Drug Discovery Industry Works

My Schedule

This Masterclass will cover a brief overview of the following topics in a small group training-session:

The commercial landscape
Human biology, pathology and drug targets
Drug discovery and development
Industry pressures and responses
Industry in transition

Speakers

Edward Zanders

Owner

PharmaGuide Ltd

L3

My Schedule

Technical Session One - An Insight into 'Adaptive' Clinical Trials

Monday, 05 Oct 2020

11:30 - 12:15

Technical Session

English

Technical Session - kindly sponsored by ThermoFisher Scientific

Technical Session One - An Insight into 'Adaptive' Clinical Trials

My Schedule

Sessions

Speakers

Speakers

Sponsors

Sponsors